CA2252918A1 - Inhibiteurs de la protease du vih utiles dans le traitement du sida - Google Patents

Inhibiteurs de la protease du vih utiles dans le traitement du sida Download PDF

Info

Publication number
CA2252918A1
CA2252918A1 CA002252918A CA2252918A CA2252918A1 CA 2252918 A1 CA2252918 A1 CA 2252918A1 CA 002252918 A CA002252918 A CA 002252918A CA 2252918 A CA2252918 A CA 2252918A CA 2252918 A1 CA2252918 A1 CA 2252918A1
Authority
CA
Canada
Prior art keywords
compound
substituted
unsubstituted
4alkyl
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002252918A
Other languages
English (en)
Inventor
Randall W. Hungate
Byeong Moon Kim
Joseph P. Vacca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613488.7A external-priority patent/GB9613488D0/en
Application filed by Individual filed Critical Individual
Publication of CA2252918A1 publication Critical patent/CA2252918A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Des analogues de peptides contenant du norbornène sont des inhibiteurs de la protéase du VIH. Ces composés, utiles dans la prévention ou le traitement d'une infection par le VIH et dans le traitement du sida, se présentent sous forme de composés, de sels acceptables en pharmacologie ou d'ingrédients de compositions pharmaceutiques, séparément ou en combinaison avec d'autres antiviraux, immunomodulateurs, antibiotiques ou vaccins. Des méthodes permettant de traiter le sida et de prévenir ou de traiter une infection par le VIH sont également décrites.
CA002252918A 1996-05-02 1997-04-29 Inhibiteurs de la protease du vih utiles dans le traitement du sida Abandoned CA2252918A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1668596P 1996-05-02 1996-05-02
US60/016,685 1996-05-02
GBGB9613488.7A GB9613488D0 (en) 1996-06-27 1996-06-27 HIV protease inhibitors useful in the treatment of aids
GB9613488.7 1996-06-27

Publications (1)

Publication Number Publication Date
CA2252918A1 true CA2252918A1 (fr) 1997-11-06

Family

ID=26309580

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002252918A Abandoned CA2252918A1 (fr) 1996-05-02 1997-04-29 Inhibiteurs de la protease du vih utiles dans le traitement du sida

Country Status (5)

Country Link
EP (1) EP0912170A4 (fr)
JP (1) JP2000509389A (fr)
AU (1) AU711713B2 (fr)
CA (1) CA2252918A1 (fr)
WO (1) WO1997040825A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007023254A (ja) * 2005-06-14 2007-02-01 Fujifilm Corp 硬化促進剤、熱硬化性樹脂組成物、感光性組成物及び感光性フィルム、並びに、永久パターン及びその形成方法
ES2553635T3 (es) * 2010-11-17 2015-12-10 Actelion Pharmaceuticals Ltd. Derivados de éster spiro[2.4]heptano puenteados
JP2014520811A (ja) 2011-06-29 2014-08-25 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 統合失調症の易罹病性及び認知機能障害と関連付けられるニューロン結合の阻害剤
BR112016025659B1 (pt) 2014-05-13 2023-03-07 Novartis Ag Indutores de condrogênese, seu uso, e composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
EP0550924A1 (fr) * 1991-12-16 1993-07-14 Merck & Co. Inc. Dérivés de 2-pyrrolidinone comme inhibiteurs de la HIV protéase

Also Published As

Publication number Publication date
AU711713B2 (en) 1999-10-21
WO1997040825A1 (fr) 1997-11-06
AU2923897A (en) 1997-11-19
EP0912170A1 (fr) 1999-05-06
EP0912170A4 (fr) 2003-04-09
JP2000509389A (ja) 2000-07-25

Similar Documents

Publication Publication Date Title
EP0766674B1 (fr) Nouveaux inhibiteurs de protease de vih
AU624144B2 (en) Amino acid derivatives
AU676563B2 (en) HIV protease inhibitors useful for the treatment of AIDS
IL103613A (en) VIH protease inhibitors, and the process of preparing intermediates and pharmaceutical preparations containing them.
NZ540729A (en) Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
WO1993003013A1 (fr) Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant
HUT56064A (en) Process for producing new isoindolow derivatives and pharmaceutical compositions containing them
EP1519729A1 (fr) Composes de pyrrolotriazinone et leur utilisation dans le traitement de maladies
CA2120192A1 (fr) Inhibiteurs de la protease de vih utiles pour le traitement du sida
CA2178760C (fr) Inhibiteurs de la protease du vih
WO1994018192A1 (fr) Derives de piperazine utiles comme inhibiteurs de la protease du vih
WO2005077920A1 (fr) Composes de quinoxaline et procedes d'utilisation
PT91616A (pt) Verfahren zur herstellung von piperazindionen mit psychotroper wirkung und von pharmazeutischen zusammensetzungen die sie enthalten
CA2084800A1 (fr) Inhibiteurs du vih protease presentant un anneau lactame interne
US5650412A (en) HIV protease inhibitors useful for the treatment of AIDS
AU711713B2 (en) HIV protease inhibitors useful for the treatment of AIDS
WO1994026749A1 (fr) Inhibiteurs de la protease de vih
ES2235844T3 (es) Agentes antibacterianos.
US5811462A (en) HIV Protease inhibitors useful for the treatment of AIDS
US5068242A (en) Pyrrolidine-2-carboxylic acid derivatives and their use for psychotropic action
CA2269135A1 (fr) Derives de benzodiazepine hydrazide utilises comme inhibiteurs de l'integrase du vih
CA2076204A1 (fr) Inhibiteurs de la vih protease avec substituants plyether n-terminaux
US5747540A (en) HIV protease inhibitors useful for the treatment of AIDS
JPS58148871A (ja) チアザスピラン誘導体類、それらの製造法、および薬物
AU712120B2 (en) HIV protease inhibitors useful for the treatment of AIDS

Legal Events

Date Code Title Description
FZDE Dead